How is the advent of adjuvant therapy in NSCLC changing our approach to surgery?
touchMDT for touchONCOLOGY
Listen to a medical oncologist, a pulmonologist and a thoracic surgeon as they assess the suitability of a patient with NSCLC for surgery and expanding treatment options.
The multidisciplinary team
Medical oncologist: Dr David Planchard, France
Pulmonologist: Prof. Johan Vansteenkiste, Belgium
Thoracic surgeon: Dr Masahiro Tsuboi, Japan
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.
For further information visit our website…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.